Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention.

IF 2.7 3区 医学 Q3 ONCOLOGY
Strahlentherapie und Onkologie Pub Date : 2025-04-01 Epub Date: 2025-02-20 DOI:10.1007/s00066-024-02362-z
Aline Van der Vorst, Maarten Lambrecht, Lucas Van Aelst, Jelle Verhoeven, Johanna Jacobs, Adinda Baten, Caroline Weltens
{"title":"Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention.","authors":"Aline Van der Vorst, Maarten Lambrecht, Lucas Van Aelst, Jelle Verhoeven, Johanna Jacobs, Adinda Baten, Caroline Weltens","doi":"10.1007/s00066-024-02362-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is the most prevalent cancer in women worldwide; nevertheless, the prognosis is good, with a 5-year overall survival of 80-90%. Therefore, it becomes crucial to strive for high quality of life after cure by minimizing treatment-related toxicity. One such concern is radiation-induced heart disease, which remains a significant focus of ongoing investigations.</p><p><strong>Purpose: </strong>The aim of this review is to summarize current knowledge on radiation-induced heart disease in breast cancer patients by giving an overview of its epidemiology, risk factors, radiation parameters related to its development, solutions in radiation practice, and prevention. The goal is to raise awareness and maximize prevention of radiation-induced heart disease.</p><p><strong>Methods: </strong>The PubMed database was screened for articles published between January 2013 and November 2023 related to the keywords <breast cancer>, <radiotherapy>, <cardiac toxicity>, and <heart-sparing techniques>. Moreover, by screening the literature lists of these publications, additional articles were added.</p><p><strong>Results: </strong>Ninety-four relevant papers remained for final review.</p><p><strong>Conclusion: </strong>Radiation-induced heart disease is a rare complication after breast cancer radiotherapy and represents a clinical spectrum of various cardiovascular conditions. Several heart-sparing techniques have been developed, and more attention has been paid to early diagnosis and prevention of radiation-induced heart disease. However, further research remains important to refine radiotherapy techniques and deepen our understanding for improved prevention and treatment of this condition in the future. This clinical review summarizes the existing evidence and literature on radiation-induced heart disease following modern breast cancer radiotherapy, offering clinical guidance for physicians.</p>","PeriodicalId":21998,"journal":{"name":"Strahlentherapie und Onkologie","volume":" ","pages":"368-382"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strahlentherapie und Onkologie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00066-024-02362-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast cancer is the most prevalent cancer in women worldwide; nevertheless, the prognosis is good, with a 5-year overall survival of 80-90%. Therefore, it becomes crucial to strive for high quality of life after cure by minimizing treatment-related toxicity. One such concern is radiation-induced heart disease, which remains a significant focus of ongoing investigations.

Purpose: The aim of this review is to summarize current knowledge on radiation-induced heart disease in breast cancer patients by giving an overview of its epidemiology, risk factors, radiation parameters related to its development, solutions in radiation practice, and prevention. The goal is to raise awareness and maximize prevention of radiation-induced heart disease.

Methods: The PubMed database was screened for articles published between January 2013 and November 2023 related to the keywords , , , and . Moreover, by screening the literature lists of these publications, additional articles were added.

Results: Ninety-four relevant papers remained for final review.

Conclusion: Radiation-induced heart disease is a rare complication after breast cancer radiotherapy and represents a clinical spectrum of various cardiovascular conditions. Several heart-sparing techniques have been developed, and more attention has been paid to early diagnosis and prevention of radiation-induced heart disease. However, further research remains important to refine radiotherapy techniques and deepen our understanding for improved prevention and treatment of this condition in the future. This clinical review summarizes the existing evidence and literature on radiation-induced heart disease following modern breast cancer radiotherapy, offering clinical guidance for physicians.

乳腺癌患者的辐射诱发心脏病:流行病学、危险因素、放疗参数和预防的叙述性回顾
背景:乳腺癌是全世界女性中最常见的癌症;然而,预后良好,5年总生存率为80-90%。因此,通过减少治疗相关的毒性来争取治愈后的高生活质量变得至关重要。其中一个担忧是辐射引起的心脏病,这仍然是正在进行的研究的重要焦点。目的:本文综述了乳腺癌患者辐射诱发心脏病的流行病学、危险因素、相关的辐射参数、放射实践中的解决方案和预防等方面的知识。其目的是提高人们对辐射引起的心脏病的认识,并最大限度地预防辐射引起的心脏病。方法:在PubMed数据库中筛选2013年1月至2023年11月期间发表的与关键词、、和相关的文章。此外,通过筛选这些出版物的文献清单,还增加了其他文章。结果:94篇相关论文留待最终审稿。结论:辐射诱发的心脏病是乳腺癌放疗后罕见的并发症,代表了多种心血管疾病的临床谱。一些心脏保护技术已经发展起来,并且越来越重视辐射引起的心脏病的早期诊断和预防。然而,进一步的研究对于改进放射治疗技术和加深我们对未来这种疾病的预防和治疗的理解仍然很重要。本文综述了现代乳腺癌放疗后辐射诱发心脏病的现有证据和文献,为临床医生提供临床指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
12.90%
发文量
141
审稿时长
3-8 weeks
期刊介绍: Strahlentherapie und Onkologie, published monthly, is a scientific journal that covers all aspects of oncology with focus on radiooncology, radiation biology and radiation physics. The articles are not only of interest to radiooncologists but to all physicians interested in oncology, to radiation biologists and radiation physicists. The journal publishes original articles, review articles and case studies that are peer-reviewed. It includes scientific short communications as well as a literature review with annotated articles that inform the reader on new developments in the various disciplines concerned and hence allow for a sound overview on the latest results in radiooncology research. Founded in 1912, Strahlentherapie und Onkologie is the oldest oncological journal in the world. Today, contributions are published in English and German. All articles have English summaries and legends. The journal is the official publication of several scientific radiooncological societies and publishes the relevant communications of these societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信